Arctic Bioscience - Achieves significant vision improvement in Clinical Glaucoma Study
18 augusti, 10:28
Arctic Bioscience - Achieves significant vision improvement in Clinical Glaucoma Study
Arctic Bioscience today announced that a clinical study published in International Ophthalmology demonstrated that daily supplementation with ROMEGA® herring caviar oil resulted in a statistically significant improvement in the visual field measure Mean Deviation (MD) in patients with primary open-angle glaucoma (POAG) and controlled intraocular pressure (IOP). No adverse events were observed, and the treatment was well tolerated.
About the study
The three-month study included 50 patients. The intervention group received one ROMEGA® capsule (500mg) daily. Results showed a clear improvement in MD values in the intervention group (p = 0.01) compared to baseline, while no similar improvement was observed in the control group. Best-corrected visual acuity and retinal nerve fiber layer thickness remained stable, and intraocular pressure was maintained.
Next steps
“These findings suggest that ROMEGA® may be a safe and potentially effective adjunct to protect vision in glaucoma patients, even when IOP is already controlled. We are now planning larger, randomized studies to confirm these promising results”, saysHogne Hallaråker, CSO in Arctic Bioscience.
Link for more info: https://pmc.ncbi.nlm.nih.gov/articles/PMC12279572/
About Arctic Bioscience
Arctic Bioscience is a biotech company developing and commercializing pharmaceutical and nutraceutical products based on unique bioactive marine compounds.
The company is developing HRO350 – a novel oral drug candidate. HRO350 is being developed for treatment of patients with mild-to-moderate psoriasis. This is a large patient group in need of new effective medicines with beneficial safety profile.
Nutraceuticals from Arctic Bioscience are sold globally as bulk ingredients as well as finished goods under the ROMEGA® brand.
Arctic Bioscience is led by a highly skilled team of talents with diverse and highly relevant background.
For more information, please contact:
Christer L. Valderhaug
CEO
Phone: +47 920 84 601
E-mail: christer@arctic-bioscience.com
Hogne Hallaråker
CSO
Phone: +47 481 20 388
E-mail: hogne@arctic-bioscience.com
Arctic Bioscience - Achieves significant vision improvement in Clinical Glaucoma Study
18 augusti, 10:28
Arctic Bioscience - Achieves significant vision improvement in Clinical Glaucoma Study
Arctic Bioscience today announced that a clinical study published in International Ophthalmology demonstrated that daily supplementation with ROMEGA® herring caviar oil resulted in a statistically significant improvement in the visual field measure Mean Deviation (MD) in patients with primary open-angle glaucoma (POAG) and controlled intraocular pressure (IOP). No adverse events were observed, and the treatment was well tolerated.
About the study
The three-month study included 50 patients. The intervention group received one ROMEGA® capsule (500mg) daily. Results showed a clear improvement in MD values in the intervention group (p = 0.01) compared to baseline, while no similar improvement was observed in the control group. Best-corrected visual acuity and retinal nerve fiber layer thickness remained stable, and intraocular pressure was maintained.
Next steps
“These findings suggest that ROMEGA® may be a safe and potentially effective adjunct to protect vision in glaucoma patients, even when IOP is already controlled. We are now planning larger, randomized studies to confirm these promising results”, saysHogne Hallaråker, CSO in Arctic Bioscience.
Link for more info: https://pmc.ncbi.nlm.nih.gov/articles/PMC12279572/
About Arctic Bioscience
Arctic Bioscience is a biotech company developing and commercializing pharmaceutical and nutraceutical products based on unique bioactive marine compounds.
The company is developing HRO350 – a novel oral drug candidate. HRO350 is being developed for treatment of patients with mild-to-moderate psoriasis. This is a large patient group in need of new effective medicines with beneficial safety profile.
Nutraceuticals from Arctic Bioscience are sold globally as bulk ingredients as well as finished goods under the ROMEGA® brand.
Arctic Bioscience is led by a highly skilled team of talents with diverse and highly relevant background.
For more information, please contact:
Christer L. Valderhaug
CEO
Phone: +47 920 84 601
E-mail: christer@arctic-bioscience.com
Hogne Hallaråker
CSO
Phone: +47 481 20 388
E-mail: hogne@arctic-bioscience.com
Aktier
Aktierekommendationer
Bostadsmarknaden
Selins sorti
Aktier
Aktierekommendationer
Bostadsmarknaden
Selins sorti
Marknadsöversikt
1 DAG %
Senast
1 mån
